Company news
Square Pharmaceuticals PLC news in 2025
Square Pharmaceuticals PLC's news releases, calls and decks from 2025, newest first.
SQURPHARMA: Consolidated profit up 14.54% with strong exports and a 120% cash dividend; standalone profit dipped
November 20, 2025
SQURPHARMA: Net revenue grew 21.7% and net profit after tax rose 21.5% year-over-year in Q1 FY2025-26
November 12, 2025
SQURPHARMA: Double-digit profit and revenue growth, strong balance sheet, and robust investment income
April 29, 2025
SQURPHARMA: Net profit up 13% to Tk. 12.70B; EPS and NAV per share both increased year-over-year
February 7, 2025
SQURPHARMA: Net profit rose 13% year-over-year, with EPS at Tk. 14.32 and strong asset growth
January 28, 2025